Loading...
•
Dec 31, 2022
LeMaitre Vascular Q4 2022 Earnings Report
LeMaitre Vascular's Q4 2022 financial performance was reported, showing sales growth and strategic investments in factory expansion and sales representatives.
Key Takeaways
LeMaitre Vascular reported a 4% increase in sales to $41.0 million in Q4 2022, with organic sales growth of 8%. Operating income decreased by 16% to $7.0 million, while net income declined by 9% to $5.6 million. The company announced a quarterly dividend of $0.14 per share and provided Q1 2023 sales guidance of $42.6 million to $45.0 million.
Sales reached $41.0 million, reflecting a 4% increase compared to Q4 2021, with organic sales up by 8%.
Operating income decreased by 16% to $7.0 million.
Net income declined by 9% to $5.6 million.
Earnings per diluted share decreased by 9% to $0.25.
Cash and investments increased by $3.0 million to $82.7 million.
Forward Guidance
LeMaitre Vascular provided Q1 2023 sales guidance of $42.6 million to $45.0 million, representing an 11% increase as reported and a 13% increase organically. Operating income is projected to be between $6.0 million and $7.5 million, and EPS is expected to be between $0.22 and $0.27.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...